China SXT Pharmaceuticals, Inc.
SXTC
$4.09
$0.7923.94%
NASDAQ
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
--
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 28.32M | 28.32M | 21.31M | 21.31M | 18.24M |
| Total Receivables | 3.23M | 3.23M | 2.87M | 2.87M | 1.90M |
| Inventory | 2.96M | 2.96M | 1.84M | 1.84M | 1.13M |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 400.00 | 400.00 | 31.00K | 31.00K | 30.40K |
| Total Current Assets | 34.51M | 34.51M | 26.04M | 26.04M | 21.30M |
|
|
|||||
| Total Current Assets | 34.51M | 34.51M | 26.04M | 26.04M | 21.30M |
| Net Property, Plant & Equipment | 238.50K | 238.50K | 302.40K | 302.40K | 355.20K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 6.30K | 6.30K | 8.50K | 8.50K | 11.80K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 34.75M | 34.75M | 26.35M | 26.35M | 21.66M |
|
|
|||||
| Total Accounts Payable | 497.60K | 497.60K | 530.70K | 530.70K | 1.16M |
| Total Accrued Expenses | 1.93M | 1.93M | 2.08M | 2.08M | 1.78M |
| Short-term Debt | 355.20K | 355.20K | 976.40K | 976.40K | 702.20K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 68.00K | 68.00K | 68.60K | 68.60K | 70.00K |
| Total Finance Division Other Current Liabilities | 1.50M | 1.50M | 2.30M | 2.30M | 2.30M |
| Total Other Current Liabilities | 1.50M | 1.50M | 2.30M | 2.30M | 2.30M |
| Total Current Liabilities | 4.35M | 4.35M | 5.96M | 5.96M | 6.01M |
|
|
|||||
| Total Current Liabilities | 4.35M | 4.35M | 5.96M | 5.96M | 6.01M |
| Long-Term Debt | 644.40K | 644.40K | 73.10K | 73.10K | 96.30K |
| Short-term Debt | 355.20K | 355.20K | 976.40K | 976.40K | 702.20K |
| Capital Leases | 53.40K | 53.40K | 85.20K | 85.20K | 115.40K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | 0.00 | 0.00 | -- |
| Total Liabilities | 5.05M | 5.05M | 6.12M | 6.12M | 6.22M |
|
|
|||||
| Common Stock & APIC | 64.13M | 64.13M | 55.38M | 55.38M | 44.53M |
| Retained Earnings | -34.22M | -34.22M | -34.38M | -34.38M | -28.02M |
| Treasury Stock & Other | -197.90K | -197.90K | -767.00K | -767.00K | -1.08M |
| Total Common Equity | 29.71M | 29.71M | 20.23M | 20.23M | 15.44M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 29.71M | 29.71M | 20.23M | 20.23M | 15.44M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 29.71M | 29.71M | 20.23M | 20.23M | 15.44M |
|
|
|||||